Ten tips reflect shift toward bimanual microincision phaco
November 15th 2004The growing trend in bimanualmicroincision phacoemulsification has prompted many surgeons to evaluate this new surgical technique. Following are 10 tips for the beginning microincision surgeon. Some of these tips may also help the more experienced surgeon fine-tune his or her approach to bimanual microincision surgery.
Retina specialist, inventor highlight of 'Current Concepts'
November 15th 2004Baltimore-The Wilmer Eye Institute's 17th annual Current Concepts in Ophthalmology meeting will feature a presentation by retinal translocation inventor Eugene de Juan Jr., MD, along with 3 days of courses and workshops designed to provide the latest updates in the field. Co-sponsored by Johns Hopkins University School of Medicine, Baltimore, and Ophthalmology Times, the meeting will convene Dec. 2 to 4.
Refractive practices revealed in annual survey
November 15th 2004New Orleans-"Hot-off-the-press" results from the 2004 International Society of Refractive Surgery of the American Academy of Ophthalmology (ISRS/AAO) refractive surgery survey are being examined to determine what constitutes standard of care, said Richard J. Duffey, MD, at the opening day session of the refractive subspecialty day meeting.
Subtle gene defects may underlie some AMD cases
November 1st 2004Iowa City, IA-Investigators here have identified subtle gene defects that underlie some cases of age-related macular degeneration (AMD), providing clues to the origin and possibly treatment of the condition, but at the same time suggesting a broad molecular-biological diversity.
Study compares wavefront-driven and conventional LASIK
November 1st 2004Los Angeles-Conventional LASIK for the treatment of myopia using the scanning slit excimer laser system (EC-5000, Nidek) affords visual acuity, predictability, and safety outcomes that are comparable to-if not slightly better than-those achieved with Hartmann-Shack aberrometer-driven ablations with other laser systems, according to the preliminary results of a retrospective study performed by Paul J. Dougherty, MD.
Animal knockout models offer platform for AMD studies
November 1st 2004Lexington, KY-Mice deficient in monocyte chemoattractant protein-1 (Ccl-2) or its cognate C-C chemokine receptor-2 (Ccr-2) provide a high-fidelity model of atrophic and neovascular age-related macular degeneration (AMD), and studies performed with those animals so far implicate a role for macrophage dysfunction in AMD pathogenesis, said Jayakrishna Ambati, MD.
Subtle gene defects may underlie some AMD cases
November 1st 2004Iowa City, IA-Investigators here have identified subtle gene defects that underlie some cases of age-related macular degeneration (AMD), providing clues to the origin and possibly treatment of the condition, but at the same time suggesting a broad molecular-biological diversity.
Newer fluoroquinolones preferred antimicrobial prophylaxis
November 1st 2004The fourth-generation fluoroquinolones gatifloxacin 0.3% (Zymar, Allergan) and moxifloxacin 0.5% (Viga- mox, Alcon Laboratories) provide safe, potent, and broad-spectrum coverage against bacterial pathogens that are important in post-refractive surgery infections, and based on that profile should be considered the treatment of choice for antimicrobial prophylaxis in patients undergoing excimer laser refractive procedures, agree Daniel S. Durrie, MD, and William Trattler, MD.
Anti-infective, NSAID dosing varies by surgeon, procedure
November 1st 2004How nonsteroidal anti-inflammatory agents (NSAIDs) and anti-infective drugs are used during cataract and refractive procedures varies depending with the procedure and the physician performing it. A few high-volume refractive surgeons explained their regimens and why use of the drugs differs.
Seven easy steps in evaluation of fourth-nerve palsy in adults
November 1st 2004A fourth-nerve palsy is a common cause of acquired vertical diplopia in the adult. These patients typically complain of vertical diplopia and tilting (torsion) of objects. The history and exam should focus on any other neurologic signs or symptoms, recent head trauma, vasculopathic risk factors, and prior symptoms suggestive of a congenital or long-standing palsy.
Private practice safely integrates CK
November 1st 2004San Diego-An evaluation of the first group of patients to undergo conductive keratoplasty (CK) performed by Ronald Friedman, MD, indicates that the procedure can be safely used to treat hyperopia and presbyopia and is easily introduced into an average-volume practice with a refractive and cataract base.
New ketorolac solution optimized for safety and patient comfort
November 1st 2004From a patient's perspective, using a non-steroidal anti-inflammatory drug (NSAID) before and after cataract or refractive surgery can help to ease pain, swelling, and irritation, and accelerate the return of visual acuity. From a surgeon's perspective, using an NSAID reduces surgical complications and makes surgery easier: it keeps the pupils larger, allowing for quicker and less traumatic procedures. It also prevents cystoid macular edema (CME) and reduces the incidence of striae because it suppresses pain and, therefore, the patient's tendency to squeeze/rub the eyes post-surgery. This article will examine the different classes of NSAIDs, compare their analgesic and anti-inflammatory activity, and determine the potency of different NSAIDs.
Cold ultrasound technology more efficient than laser phaco
November 1st 2004San Diego-Cold ultrasound technology [WhiteStar, Advanced Medical Optics Inc. (AMO)] allows the efficient removal of all densities of cataracts and is as safe as a pulsed laser microincision phacoemulsification system. A major advantage of the cold ultrasound system is that it dramatically reduces the phacoemulsification time compared with laser phacoemulsification.